UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 27,
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more HOOKIPA Pharma Charts.
HOOKIPA Pharma (NASDAQ:HOOK)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more HOOKIPA Pharma Charts.

Hookipa Pharma Inc. News

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 16 April 2024 (3 weeks ago) • GlobeNewswire Inc.
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Wednesday 10 April 2024 (4 weeks ago) • GlobeNewswire Inc.
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Friday 22 March 2024 (1 month ago) • GlobeNewswire Inc.
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 29 January 2024 (3 months ago) • Edgar (US Regulatory)
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
Monday 29 January 2024 (3 months ago) • GlobeNewswire Inc.
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
Tuesday 16 January 2024 (4 months ago) • GlobeNewswire Inc.
Form EFFECT - Notice of Effectiveness
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Friday 22 December 2023 (4 months ago) • Edgar (US Regulatory)

More Hookipa Pharma Inc. News Articles